SARAH JAURON: Open Payments
NPI 1700156759 · DAVENPORT, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 21 payments from 14 companies in 2025. Trend: 2023 $101 · 2024 $439 · 2025 $366
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Exact Sciences Corporation | 2 | $38 |
| Novo Nordisk Inc | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| PFIZER INC. | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
Products named: ABILIFY ASIMTUFII, QULIPTA, Ozempic, CAPLYTA, PREVNAR 20, Cologuard Collection Kit, INGREZZA, UBRELVY.
Industry payments across IA — which companies pay providers there.
